Key Data Points

Primary metrics and data points about ImmunoGen.
Current Price: $6.17
Prev Close: $6.43
Open: $6.50
Bid: $6.18
Ask: $6.30
Day's Range: $6.13 - $6.59
52wk Range: $5.34 - $17.80
Volume: 1,041,279
Avg Vol 2,184,460
Market Cap: $530M
P/E (ttm): -6.70
EPS (ttm): ($0.96)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for ImmunoGen.

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drugs

Stock Charting

IMGN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about ImmunoGen.
CAPS Rating 4 out of 5
 
326 Outperform
21 Underperform
CAPS All Stars
 
72 Outperform
4 Underperform

Powered by Motley Fool CAPS


More Details about ImmunoGen

Primary metrics and data points about ImmunoGen.

Company Photos

Powered by